These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13893160)

  • 1. [Clinical-psychiatric experiences with ethyl tryptamine acetate].
    FISCHER PA
    Arztl Forsch; 1962 Aug; 16():I/429-31. PubMed ID: 13893160
    [No Abstract]   [Full Text] [Related]  

  • 2. Etryptamine acetate in general practice.
    CHOGICH JC
    J Neuropsychiatr; 1961; 3():96-7. PubMed ID: 13879126
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of geriatric patients with etryptamine acetate.
    KIESSLING AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873
    [No Abstract]   [Full Text] [Related]  

  • 4. Etryptamine acetate--a new antidepressant chemical.
    ROBIE TR
    J Neuropsychiatr; 1962; 3():181-5. PubMed ID: 14492850
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of D, L-alpha-ethyltryptamine acetate on serotonin metabolism.
    GREIG ME; GIBBONS AJ
    Arch Int Pharmacodyn Ther; 1962 Mar; 136():147-52. PubMed ID: 13901665
    [No Abstract]   [Full Text] [Related]  

  • 6. N-Methyl-alpha-methyl-tryptamine: a potent monoamine oxidase inhibitor and tryptamine antagonist.
    TEDESCHI DH; TEDESCHI RE; FOWLER PJ; GREEN H; FELLOWS EJ
    Biochem Pharmacol; 1962 Jun; 11():481-5. PubMed ID: 13920062
    [No Abstract]   [Full Text] [Related]  

  • 7. A STUDY OF THE POTENTIATION OF TRYPTAMINE BY MONOAMINE OXIDASE INHIBITORS IN THE DOG.
    EBLE JN
    J Pharmacol Exp Ther; 1965 Apr; 148():48-53. PubMed ID: 14279183
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of hypotensive effects and urinary tryptamine levels during pargyline therapy.
    ORVIS HH; TAMAGNA IG; HORWITZ D; THOMAS R
    Ann N Y Acad Sci; 1963 Jul; 107():958-65. PubMed ID: 13940449
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-ethyltryptamine acetate in alcoholism. A preliminary report.
    LAWRENCE FE
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():88-90. PubMed ID: 13759684
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-ethyltryptamine acetate in the treatment of depression, a study of the methodology of drug evaluation.
    KAST EC
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():114-8. PubMed ID: 13751710
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression--its treatment with etryptamine acetate.
    SETTEL E
    J Am Geriatr Soc; 1961 Sep; 9():755-8. PubMed ID: 13750393
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-SUBSTITUTED CYCLOPROPYLAMINES. II. EFFECT OF STRUCTURE UPON MONOAMINE OXIDASE-INHIBITORY ACTIVITY AS MEASURED IN VIVO BY POTENTIATION OF TRYPTAMINE CONVULSIONS.
    ZIRKLE CL; KAISER C; TEDESCHI DH; TEDESCHI RE; BURGER A
    J Med Pharm Chem; 1962 Nov; 5():1265-84. PubMed ID: 14056459
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of beta-carboline derivative inhibition of MAO from its action on methyl-tryptamine.
    Hsu SL
    J Jpn Obstet Gynecol Soc; 1966 Oct; 13(4):267-70. PubMed ID: 5984371
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin].
    Gorkin VZ; Tat'ianenko LV; Suvorov NN; Nekliudov AD
    Biokhimiia; 1967; 32(5):1036-46. PubMed ID: 5599890
    [No Abstract]   [Full Text] [Related]  

  • 17. Memory function of patients taking etryptamine acetate.
    BYLENGA ND; MAY RH
    J Nerv Ment Dis; 1961 Sep; 133():213-5. PubMed ID: 13875315
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the toxicology of alpha-methyl- and alpha-ethyltryptamine acetates (Monase). II. Chronic studies.
    KELLER JG; VIGUERA C; KUNDZINS W
    Toxicol Appl Pharmacol; 1962 Nov; 4():697-709. PubMed ID: 14031765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the study of attenzione in subjects subjected to thymoleptic therapy (imipramine, iproniazid, phenelzine, etryptamine)].
    MEDAGLINI E
    Riv Sper Freniatr Med Leg Alien Ment; 1962 Jun; 86():494-500. PubMed ID: 14471966
    [No Abstract]   [Full Text] [Related]  

  • 20. A monoamine oxidase inhibitor in the treatment of organic disease.
    MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.